A comprehensive review of mechanisms underlying resistance to immune checkpoint inhibitors
Immune checkpoint inhibitors (ICIs) have revolutionized the management of multiple malignancies, offering durable clinical benefit in a subset of patients. However, the emergence of distinct response patterns has revealed two major challenges: primary …